Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR and ONLY ADVR -- Ignore unavailable to you. Want to Upgrade?

To: RickV who wrote (103)	9/27/2000 6:45:16 PM
From: Bernie Bildman	Read Replies (1) \| Respond to of 278

Most who have read this see it as good news, and a few others see some loopholes in it (see Raging Bull, ceoa+ postings). Many feel the impact is that now they have in place the financing to initiate and continue the IND process into the Phase I and II studies, assuming the IND is approved. There are questions as to WHEN the IND will be filed, and whether the terms of the financing are appropriately healthy. Being that I have little (read that as less than .005%) expertise in this area, I am simply reading and trying to interpret what is being pushed forward. Of importantance is not whether SOME see the financing as good or bad, but how the community in general see this vote of confidence from a new source. That may work in the short run, however, may play against ADVR in the long run depending on how some things play out.